Gastric Endocrine Cell Proliferation and Fundic Argyrophil Carcinoid Tumors in Patients with the Zollinger-Ellison Syndrome

Authors

  • Guillaume Cadiot Department of Hepato-Gastoenterology and INSERM U10, Bichat-Claude Bernard Hospital, Paris, France
  • Thérèse Lehy Department of Hepato-Gastoenterology and INSERM U10, Bichat-Claude Bernard Hospital, Paris, France
  • Michel Mignon Department of Hepato-Gastoenterology and INSERM U10, Bichat-Claude Bernard Hospital, Paris, France

DOI:

https://doi.org/10.3109/02841869309083902

Abstract

The Zollinger-Ellison syndrome (ZES) is characterized by hyperchlorhydria due to sustained hypergastrinemia of tumoral origin. In ZES, as in all pathological and experimental conditions associated with chronic hypergastrinemia, endocrine argyrophil cells, particularly enterochromaffin-like cells, proliferate in the fundic mucosa. In patients with ZES, fundic argyrophil carcinoids only develop in those patients who also have multiple endocrine neoplasia type 1. The authors review factors which might influence fundic argyrophil cell proliferation in the ZES. Clinical characteristics of the patients with fundic argyrophil carcinoid tumors as well as pathology and the putative mechanisms of development of these tumors are described.

Downloads

Download data is not yet available.

Downloads

Published

1993-01-01

How to Cite

Cadiot, G., Lehy, T., & Mignon, M. (1993). Gastric Endocrine Cell Proliferation and Fundic Argyrophil Carcinoid Tumors in Patients with the Zollinger-Ellison Syndrome. Acta Oncologica, 32(2), 135–140. https://doi.org/10.3109/02841869309083902